GENOMICS PLC AND GSK ESTABLISH PRECISION MEDICINE COLLABORATION TO ASSESS POLYGENIC RISK SCORES IN CLINICAL TRIAL DESIGN
Genomics Plc And Gsk Establish Precision Medicine Collaboration…
![Reuters logo](/images/reuters.jpg)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,604 GBX | -0.34% |
|
-1.50% | +10.64% |
06-13 | REGENXBIO Inc. Announces Chief Executive Officer Changes | CI |
06-12 | Moderna's RSV Vaccine Has 'Ample Opportunity' Despite Seasoned Competitors, Oppenheimer Says | MT |
GENOMICS PLC AND GSK ESTABLISH PRECISION MEDICINE COLLABORATION TO ASSESS POLYGENIC RISK SCORES IN CLINICAL TRIAL DESIGN
1st Jan change | Capi. | |
---|---|---|
+10.64% | 82.98B | |
+50.70% | 791B | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B |